Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-50,522
Closed -$99.8K 8756
2023
Q1
$99.8K Sell
50,522
-160,945
-76% -$403K ﹤0.01% 8228
2022
Q4
$450K Sell
211,467
-132,427
-39% -$300K ﹤0.01% 6320
2022
Q3
$819K Sell
343,894
-146,336
-30% -$443K ﹤0.01% 5793
2022
Q2
$1.36M Sell
490,230
-113,023
-19% -$398K ﹤0.01% 4902
2022
Q1
$2.79M Buy
603,253
+376,862
+166% +$2.08M ﹤0.01% 4109
2021
Q4
$1.92M Buy
226,391
+56,105
+33% +$551K ﹤0.01% 4583
2021
Q3
$2.21M Buy
+170,286
New +$2.36M ﹤0.01% 4273
2021
Q1
Sell
-156,573
Closed -$4.67M 9127
2020
Q4
$4.67M Buy
156,573
+141,048
+909% +$3.16M ﹤0.01% 2224
2020
Q3
$288K Buy
+15,525
New +$275K ﹤0.01% 5926
2019
Q4
Sell
-22,672
Closed -$233K 5107
2019
Q3
$233K Buy
+22,672
New +$305K ﹤0.01% 4464
2018
Q3
Sell
-43,820
Closed -$1.26M 5131
2018
Q2
$1.26M Sell
43,820
-4,602
-10% -$137K ﹤0.01% 2465
2018
Q1
$1.54M Buy
+48,422
New +$1.53M ﹤0.01% 2159
2015
Q4
Sell
-36,219
Closed -$968K 4025
2015
Q3
$968K Buy
+36,219
New +$1.21M 0.01% 1661

Other funds holding CLLS

Jane Street's CLLS Position: Q2 2023 in Review

Jane Street sold out of Cellectis (CLLS) in Q2 2023, closing a stake of 50,522 shares — an estimated $99.8K sold.

Jane Street first reported a position in CLLS in Q3 2015 and held it in 13 quarters. The position peaked at $4.67M in Q4 2020. 36 funds tracked by Wall St. Rank hold CLLS as of Q2 2023.

  • Jane Street reported no remaining Cellectis position as of Q2 2023 after selling out during the quarter.
  • Jane Street sold 50,522 Cellectis shares in Q2 2023, an estimated $99.8K.
  • Jane Street first reported a position in Cellectis in Q3 2015 and held it in 13 quarters.
  • Jane Street's Cellectis position peaked at $4.67M in Q4 2020.
  • 36 funds tracked by Wall St. Rank held Cellectis as of Q2 2023.

Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.